{
    "pmcid": "7832525",
    "qa_pairs": {
        "How can nanobodies be humanized to reduce immunogenicity according to the paper?": [
            "By modifying their amino acid sequences to resemble human antibody frameworks.",
            "By conjugating them with polyethylene glycol to mask foreign epitopes.",
            "By incorporating human glycosylation patterns to mimic human antibodies.",
            "By fusing them with human albumin to increase their molecular weight."
        ],
        "What are the structural origins of nanobodies as described in the paper?": [
            "Nanobodies are derived from heavy-chain antibodies (HCAbs) found in camelids and sharks.",
            "Nanobodies are derived from light-chain antibodies found in humans and mice.",
            "Nanobodies are derived from single-chain antibodies found in reptiles and amphibians.",
            "Nanobodies are derived from full-length antibodies found in birds and fish."
        ],
        "What strategies are mentioned for enhancing the efficacy of nanobodies against SARS-CoV-2?": [
            "Dimerization, trimerization, and fusion with human Fc domains.",
            "Monomerization, glycosylation, and fusion with viral proteins.",
            "Phosphorylation, acetylation, and fusion with bacterial toxins.",
            "Methylation, ubiquitination, and fusion with plant lectins."
        ],
        "What techniques are used for constructing and screening nanobody libraries?": [
            "Phage display and yeast surface display.",
            "Bacterial two-hybrid and mammalian two-hybrid.",
            "CRISPR-Cas9 and RNA interference.",
            "Flow cytometry and mass spectrometry."
        ],
        "Which protein is primarily targeted by nanobodies for SARS-CoV-2 neutralization?": [
            "The spike protein, particularly the receptor-binding domain (RBD).",
            "The nucleocapsid protein, particularly the RNA-binding domain.",
            "The membrane protein, particularly the transmembrane domain.",
            "The envelope protein, particularly the ion channel domain."
        ]
    }
}